The rising prevalence of end stage renal disease and surge in demand for home dialysis treatment are anticipated to drive the global peritoneal dialysis market, finds Fortune Business Insights in a new study. The study is titled “Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global market will rise at 6.9% CAGR and reach a value of US$ 6,077.2 Mn by 2025 from US$ 3,589.9 Mn.
KEY COMPANIES MENTIONED IN REPORT
- Baxter International Inc.
- Fresenius Kabi
- Utah Medical Products
- Glomeria Therapeutics
- Poly Medicure Ltd.
- Cook Medical
- CardioMed Supplies Inc.
- Medical Components, Inc.
Other factors driving the global peritoneal dialysis market are the increasing prevalence of end stage renal disease (ESRD), and the increasing demand for dialysis treatment at home setup. Moreover, peritoneal dialysis offers advantages such as needle free treatment, portability, few dietary restrictions, and lower treatment cost as compared to hemodialysis, that are further increasing its potentiality for better results in the future. Thus, the market for peritoneal dialysis is likely to witness progressive growth rates owing to factors mentioned above in the near future.
Rising Preference for Dialysis Treatment at Home to Drive Market
The Global Peritoneal Dialysis Market is witnessing growth due to several reasons. One of the major factors propelling demand for the market is the increasing geriatric population and their vulnerability towards chronic disorders such as hypertension, diabetes, and kidney disorders. Besides recent advancements in technology, patients are likely to opt for peritoneal dialysis due to the rise in their disposable income and increasing willingness to spend on advanced treatments. The above factors all help the peritoneal dialysis market exhibit a steady growth in the future.
The automated peritoneal dialysis (APD) segment emerged as the most attractive therapy type in the past. It is one of the preferred types of renal replacement treatment among people suffering from end-stage renal diseases. In 2015, National Center for Biotechnology Information (NCBI) published an article, which stated that about 60% of the patients in the U.S., diagnosed with peritoneal dialysis prefer APD rather than other treatment methods, while the number of people opting for APD in Europe is 50%. This is because of the recent advancements in the technology, increasing popularity of the cycler, and new product developments that APD is further expected to continue its dominance during the forecast period.
- Other Accessories
By End User
- Home health care
- Hospitals and Others